









Markets
/
Stocks
/
nasdaq-nvst
/

Envista Holdings Corp

NVST

26.140USD

+0.110+0.42%

Close 03/25, 16:00（ET）Quotes delayed by 15 min

4.04BMarket Cap

93.44P/E TTM



Envista Holdings Corp

26.140

+0.110+0.42%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Envista Holdings Corp

Currency: USD Updated: 2026-03-24

Key Insights

Envista Holdings Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 7 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.91.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Envista Holdings Corp's Score

Industry at a Glance

Industry Ranking

7 / 209

Overall Ranking

65 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Envista Holdings Corp Highlights

StrengthsRisks

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Overvalued

The company’s latest PE is 93.04, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 191.18M shares, decreasing 13.41% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 921.00 shares of this stock.

Analyst Rating

Based on 14 analysts

Buy

Current Rating

28.909

Target Price

+16.15%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-24

The current financial score of Envista Holdings Corp is 8.46, ranking 30 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 750.60M, representing a year-over-year increase of 14.96%, while its net profit experienced a year-over-year increase of 2641.67%.

Score

Industry at a Glance

Previous score

8.46

Change



Financials

9.12

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.85

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.85

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.20

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.31

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Envista Holdings Corp's Company Valuation

Currency: USD Updated: 2026-03-24

The current valuation score of Envista Holdings Corp is 7.77, ranking 58 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 93.04, which is 188.34% below the recent high of 268.28 and 145.56% above the recent low of -42.39.

Score

Industry at a Glance

Previous score

7.77

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 7/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-24

The current earnings forecast score of Envista Holdings Corp is 7.60, ranking 128 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 22.00, with a high of 27.00 and a low of 18.00.

Score

Industry at a Glance

Previous score

7.60

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 14 analysts

Buy

Current Rating

28.909

Target Price

+11.96%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Envista Holdings Corp

NVST

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-24

The current price momentum score of Envista Holdings Corp is 7.06, ranking 48 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 29.23 and the support level at 23.53, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.02

Change

0.04

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.228

Sell

RSI(14)

48.278

Neutral

STOCH(KDJ)(9,3,3)

70.411

Buy

ATR(14)

1.124

Low Volatility

CCI(14)

41.535

Neutral

Williams %R

43.452

Buy

TRIX(12,20)

-0.386

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

25.628

Buy

MA10

25.448

Buy

MA20

26.681

Sell

MA50

26.419

Sell

MA100

23.734

Buy

MA200

21.978

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-24

The current institutional shareholding score of Envista Holdings Corp is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 116.72%, representing a quarter-over-quarter decrease of 2.33%. The largest institutional shareholder is The Vanguard, holding a total of 16.04M shares, representing 9.79% of shares outstanding, with 2.53% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

16.33M

-3.50%

BlackRock Institutional Trust Company, N.A.

14.32M

-2.56%

Ariel Investments, LLC

Star Investors

12.00M

-2.84%

Dimensional Fund Advisors, L.P.

9.54M

+4.01%

Franklin Mutual Advisers, LLC

8.69M

-2.93%

Atlanta Capital Management Company, L.L.C.

8.67M

-19.86%

Victory Capital Management Inc.

5.91M

+2.79%

AllianceBernstein L.P.

6.10M

+0.00%

Gates Capital Management, Inc.

6.22M

-1.66%

State Street Investment Management (US)

5.31M

-3.92%

Risk Assessment

Currency: USD Updated: 2026-03-24

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Envista Holdings Corp is 8.38, ranking 22 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.